Inveresk Research Group, Inc. Reports Completion of Common Stock Offering, Full Exercise of Underwriters' Over-Allotment Option
November 25 2003 - 4:15PM
PR Newswire (US)
Inveresk Research Group, Inc. Reports Completion of Common Stock
Offering, Full Exercise of Underwriters' Over-Allotment Option
CARY, N.C., Nov. 25 /PRNewswire-FirstCall/ -- Inveresk Research
Group, Inc. today announced the closing of a public offering of
11,500,000 shares of its common stock, including 1,500,000 shares
that were sold upon the exercise in full of the underwriters'
over-allotment option. The public offering price was $20.00 per
share. The offering was comprised of 10,500,000 shares sold by
various selling stockholders, including the 1,500,000 shares sold
pursuant to the underwriters' over-allotment option, and 1,000,000
shares sold by Inveresk. The underwriters for the offering were
Bear, Stearns & Co. Inc., Goldman, Sachs & Co., William
Blair & Company, L.L.C., SG Cowen Securities Corporation and
Jefferies & Company, Inc. This press release shall not
constitute an offer to sell or the solicitation of an offer to buy
nor shall there be any sale of these shares in any state in which
such offer, solicitation or sale would be unlawful prior to
registration or qualification under the securities laws of any such
state. Copies of the prospectus and prospectus supplement relating
to these securities may be obtained by contacting Bear, Stearns
& Co. Inc., 383 Madison Avenue, New York, NY 10179, telephone
number 212-272-2000. Inveresk is a leading provider of drug
development services to companies in the pharmaceutical and
biotechnology industries. The company is based in Cary, North
Carolina with facilities in Edinburgh, Scotland and Montreal,
Canada. DATASOURCE: Inveresk Research Group, Inc. CONTACT: Deborah
Ardern-Jones, +1-212-850-5626, for Inveresk Research Group, Inc.
Copyright
Inveresk (NASDAQ:IRGI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Inveresk (NASDAQ:IRGI)
Historical Stock Chart
From Sep 2023 to Sep 2024